Can an inhaled drug help reduce anxiety?
Part of Mental health clinical trials.
This study tests an inhaled medication called NC-107 to see if it can safely reduce anxiety symptoms compared to a placebo over 4 weeks. It is for adults with generalized anxiety disorder who have not used cannabis regularly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and have a diagnosis of generalized anxiety disorder with moderate anxiety (STAI score of 16 or higher or GAD-7 score of 10 or higher).
- You must not have used cannabis more than once a month in the past 6 months and must have a negative urine drug screen for THC.
- Your current anxiety medication(s) must have been stable (no changes) for at least 3 months.
- Women must not be pregnant, breastfeeding, or planning pregnancy and must use an approved form of birth control if of childbearing age.
- You must not have serious heart, kidney, liver, or uncontrolled diabetes problems, or certain other psychiatric conditions like major depression or bipolar disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests whether specific respiratory (breathing) training can reduce anxiety symptoms and fear responses. It may help people who have several kinds of anxiety or trauma-related anxiety, especially if they are not on anxiety medicines or only stable on them.
This trial tests a new medication called RE104 for people with generalized anxiety disorder (GAD). The goal is to see if it helps reduce anxiety symptoms safely.
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
This study tests whether a cannabis-like drug can help people with higher-than-normal anxiety cope with a night of very little sleep. You will be asked to sleep only 4 hours on one occasion.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.